Focus, memory, and cellular energy, and how big each study really was.

• The best known human trial had 26 people. Rodriguez and colleagues ran a randomized, placebo-controlled trial, published in Radiology in 2016, and scanned brains about an hour after a single dose.
• That trial reported about 7 percent more correct answers on a memory test. It used a single 280 mg dose, far more than a daily supplement.
• Energy and aging findings come mostly from the lab. Higher oxygen use and delayed signs of aging were measured in cultured human cells.

Important: Methylene blue has documented interactions with serotonergic medications including SSRIs and MAOIs. Review the full adverse medications list before starting any methylene blue protocol.

A result in a petri dish is a starting point. A result in rats is a step closer. A randomized, placebo-controlled trial in people is the strongest kind of single study, and a review of many trials is stronger still.

Methylene blue research now spans every layer, from cell studies through animal work to randomized, placebo-controlled human trials.

Every study in this module is labeled with what kind it is, so you can weigh it yourself.

In a randomized, placebo-controlled trial published in Radiology in 2016, Rodriguez and colleagues gave 26 healthy adults a single dose of methylene blue or a placebo and scanned their brains about an hour later.^[8]

They reported more brain response during an attention task in the methylene blue group, in regions tied to attention and short-term memory.

It is a randomized trial with a placebo group, the gold standard design, and it remains one of the most cited methylene blue studies.

In the same 2016 trial, people who took methylene blue got about 7 percent more correct answers on a memory test. A 2017 follow-up by the same group reported stronger connections between brain regions tied to perception and memory.^[8,9,10]

In rats, Riha and colleagues reported in 2005 that a low dose helped memory while high doses did not, which matches the hormetic curve from Module 3.

Results like these are why methylene blue has become one of the most closely watched compounds in brain energy research.

Reviews by Rojas (2012) and Tucker (2018) describe methylene blue passing electrons along inside mitochondria. In cultured human cells, Atamna and colleagues measured higher oxygen use in 2008, a sign the energy chain was working harder.^[4,5,11]

This is the mechanism behind most of the interest in methylene blue as a supplement. It is also mostly lab work.

When people describe steadier energy on methylene blue, this is the research they are usually pointing to.

Atamna's 2008 study also reported that methylene blue delayed signs of aging in cultured human cells. A 2021 review by Xue and colleagues in the journal Cells collected this and related work under the heading of anti-aging research.^[11,3]

This work has made methylene blue one of the most discussed compounds in longevity science. The findings so far come from lab and animal studies.

Knowing what kind of evidence each claim rests on is what separates real knowledge from internet hype.

The landmark human trial gave 26 adults a single 280 mg dose and measured clear changes in brain activity and memory. Daily supplements use far smaller amounts, built around the low end of the hormetic curve.^[8]

The next step in the field is longer studies of small daily amounts in healthy people. Interest from researchers has grown every year, and we follow each new paper as it comes out.

When new research is published, this course is updated. Supplemental methylene blue is not approved to treat, cure, or prevent any disease.

Methylene blue research runs from cell studies to randomized human trials. The human trials so far gave a single dose, and longer studies of small daily amounts are the next step.

• A randomized, placebo-controlled human trial is the strongest single study, and a review of many trials is stronger still.
• The 2016 trial reported more brain response during an attention task.
• A 2017 follow-up reported stronger connections between brain regions tied to perception and memory.
• In rats, a low dose helped memory and high doses did not (Riha and colleagues, 2005).
• The aging-cell findings collected in the 2021 Xue review have not been shown in people yet.

Peer-reviewed research and history